Some clients also have acquired prior cytotoxic therapy, both as adjuvant procedure or for metastatic disorder.crofelemer increases levels of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Crofelemer has the probable to inhibit CYP3A4 at concentrations anticipated within the gut; unlikely to inhibit systemic